Depixus

Depixus is developing a set of technologies to enable the fast, accurate, and inexpensive extraction of genetic and epigenetic information from single molecules of DNA and RNA. Validation of many of Depixus' technologies is at an advanced stage and commercial development is well underway. The company has strong backing from a group of very experienced angel investors, several of whom are veterans of the sequencing industry.